Investigational Drug Information for Olorofim
✉ Email this page to a colleague
What is the development status for investigational drug Olorofim?
Olorofim is an investigational drug.
There have been 7 clinical trials for Olorofim.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 30th 2021.
The most common disease conditions in clinical trials are Mycoses, Invasive Fungal Infections, and Renal Insufficiency. The leading clinical trial sponsors are F2G Biotech GmbH, F2G Ltd., and Iqvia Pty Ltd.
There are two US patents protecting this investigational drug and twenty-five international patents.
Summary for Olorofim
| US Patents | 2 |
| International Patents | 25 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2021-11-30) |
| Vendors | 29 |
Recent Clinical Trials for Olorofim
| Title | Sponsor | Phase |
|---|---|---|
| A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment | F2G Biotech GmbH | Phase 1 |
| Olorofim Aspergillus Infection Study | Iqvia Pty Ltd | Phase 3 |
| Olorofim Aspergillus Infection Study | F2G Biotech GmbH | Phase 3 |
Clinical Trial Summary for Olorofim
Top disease conditions for Olorofim
Top clinical trial sponsors for Olorofim
US Patents for Olorofim
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Olorofim | ⤷ Subscribe | Antifungal agents | F2G LIMITED (Manchester, GB) | ⤷ Subscribe |
| Olorofim | ⤷ Subscribe | Antifungal agents | F2G LIMITED (Manchester, GB) | ⤷ Subscribe |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Olorofim
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Olorofim | Australia | AU2015348043 | 2034-11-21 | ⤷ Subscribe |
| Olorofim | Brazil | BR112017010439 | 2034-11-21 | ⤷ Subscribe |
| Olorofim | Canada | CA2982660 | 2034-11-21 | ⤷ Subscribe |
| Olorofim | China | CN107207470 | 2034-11-21 | ⤷ Subscribe |
| Olorofim | China | CN111096967 | 2034-11-21 | ⤷ Subscribe |
| Olorofim | Cyprus | CY1120907 | 2034-11-21 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
